In an interview with Targeted Oncology, George Mulligan, PhD, discussed the key takeaways from analysis of the Immune Atlas for multiple myeloma and what will come next now that this dataset has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results